A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Start Date
2/9/2026
Completion Date
11/23/2028
Summary
The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Blood sample collection
Conditions
Locations
University Of California Davis, Neurological Surgery
Sacramento, California 95817
United States
University of California San Francisco
San Francisco, California 94110
United States
Goodman Campbell Brain and Spine/Ascension
Carmel, Indiana 46032
United States
Northwell Health - Department Of Neurosurgery
Manhasset, New York 11030
United States
Atrium Health - Carolina Medical Center
Charlotte, North Carolina 28203
United States
University of Cincinnati
Cincinnati, Ohio 45229
United States
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania 19104
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15213
United States
Brown University
Providence, Rhode Island 29903
United States
Vanderbilt University Medical Center
Nashville, Tennessee 37203
United States
University of Utah
Salt Lake City, Utah 84132
United States
University of Wisconsin
Madison, Wisconsin 53792
United States
Medical College of Wisconsin
Milwaukee, Wisconsin 53226
United States